Skip to main content

Table 1 Characterization of patients

From: Methotrexate upregulates circadian transcriptional factors PAR bZIP to induce apoptosis on rheumatoid arthritis synovial fibroblasts

Characteristic Value
Patients (n) 10
Age (years) 59.3 ± 3.4
Sex (female/male) 8/2
Disease duration (years) 22.7 ± 3.2
C-reactive protein (mg/dl) 1.2 ± 0.4
DAS28-ESR 2.6 ± 0.4
Methotrexate (mg/week) 7.4 ± 1.4
Methylprednisolone (mg) 3.7 ± 0.9
Other DMARDs
 Adalimumab 2/10
 Tocilizumab 2/10
 Tacrolimus 2/10 (2, 1.5 mg)
 Etanercept 2/10
 Infliximab 1/10
 None 2/10